Scientists reduced blood clotting in mice with a blood disease called myeloproliferative neoplasm by inhibiting expression of a gene.
Browsing: Will Doss
A team from Northwestern Medicine used the most powerful X-ray source in the Western Hemisphere to examine an 1,800-year old mummy, seeking answers to questions about bone competence of ancient humans.
Northwestern Medicine scientists identified a complex regulatory system that keeps cells functioning when their oxygen supply is cut off.
The 7th Annual Les Turner Symposium showcased the integration of ALS investigation and clinical care at Northwestern Medicine and the Les Turner ALS Foundation.
New cross-cutting themes and a disease focus area were added to Feinberg’s research strategy, strengthening the vision for years to come.
Northwestern Medicine scientists have discovered a genetic basis for glaucoma symptoms and the impact of other genes in early retinal development.
Two Northwestern Medicine clinical trials investigated drugs to treat patients suffering from vasodilatory shock and respiratory failure, showing promising results.
Northwestern Medicine investigators applied discovery-based proteomics to identify synaptic protein interactions that possibly contribute to autism spectrum disorders.
Patients with advanced neuroendocrine tumors had a similar quality of life while on a newly approved chemotherapy drug, as compared to patients receiving a placebo, according to a Northwestern Medicine study.
Northwestern Medicine scientists have published a paper in Nature Chemical Biology, detailing an innovative use of CRISPR-Cas9 technology that has helped reveal how oxidative stress explains a common herbicide’s link to risk of Parkinson’s.